Abnova (Taiwan) Corporation (TPE:4133)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
23.70
-0.75 (-3.07%)
Mar 4, 2026, 1:35 PM CST
Market Cap1.48B -20.0%
Revenue (ttm)351.30M -1.1%
Net Income-1.14M
EPS-0.02
Shares Out60.55M
PE Ration/a
Forward PEn/a
Dividend0.90 (3.58%)
Ex-Dividend DateJun 16, 2025
Volume190,455
Average Volume584,500
Open24.40
Previous Close24.45
Day's Range23.60 - 24.85
52-Week Range21.70 - 35.10
Beta0.50
RSI44.73
Earnings DateFeb 26, 2026

About Abnova (Taiwan)

Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies. The company’s products portfolio includes SARS-CoV/CoV-2 DNA, RNA, proteins/peptides, lysates/slides, Ab pairs/kits, Ab arrays, polyclinic antibody, beads/dyes, in situ hybridization products, systems, and automations. It also offers MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating rare cell antibodies. In addition, the company provides integrated solutions and services, including gene synthesis an... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 4133
Full Company Profile

Financial Performance

Financial Statements